[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (4): 306-308.doi: 10.3736/jcim20090402

• Original Clinical Research • Previous Articles     Next Articles

Thinking on syndrome differentiation treatment and personalized therapy for tumor

Jing Li   

  1. Department of Traditional Chinese Medicine, the Fourth Hospital, Hebei Medical University, Shijiazhuang 050011,Hebei Province, China
  • Received:2008-12-04 Accepted:2009-02-04 Online:2009-04-20 Published:2009-04-15

The concepts of Western medicine in treating tumor have changed markedly in recent years, and begun to put more emphasis on the whole survival status of patients. With recent emergence of targeted drugs, it was found that curative effects of the same targeted drugs in treating patients with the same tumor type even the same tumor pathological subtype but different therapeutic targets may be different. On the contrary, the curative effects of different targeted drugs in treating patients with different tumor types but the same therapeutic targets may be similar. Accordingly, the viewpoint of personalized therapy is advocated in Western medicine. Under the guidance of syndrome differentiation treatment in traditional Chinese medicine (TCM), patients with the same tumor and different syndromes should be treated by different herbs, and patients with different tumor and the same syndrome should be treated by the same herbs. Both the theories of "the same treatment for the same syndrome" and "the same treatment for the same therapeutic target" indicate that personalized therapy in Western medicine is similar to TCM syndrome differentiation treatment. The article focuses on "different treatments for the same disease" as well as "the same treatment for different diseases" to describe the similar points between personalized therapy and TCM syndrome differentiation treatment and thereby proves that TCM syndrome differentiation treatment is a scientific and essential approach in treating tumor. At the same time, the article also points out the problems and solution methods of TCM syndrome differentiation treatment.

Key words: Syndrome differentiation treatment, Personalized therapy, Neoplasms, Traditional Chinese medicine

[1] Zhang XY, Xu LY, Wang H, Zhu YZ, Liu Z, Yue WT, Tang JF, Wu W, Liu Z, Wu YH, Zhang CY, Shi YK, Wang MZ, Shi HL, Li MZ, Meng QY, Guo LL, Wang JH, Li XB . The relationship between EGFR mutations and response and prognosis of tyrosine kinase inhibitors in advanced non-small-cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2008,11(2):206-213
张新勇, 徐丽艳, 汪惠, 朱允中, 刘喆, 岳文涛, 唐俊舫, 武玮, 刘赞, 吴羽华, 张春彦, 石远凯, 王孟昭, 史鹤玲, 李明智, 孟弃逸, 郭丽丽, 王敬慧, 李雪冰 . EGFR基因突变与酪氨酸激酶抑制剂疗效及预后之间的关系[J]. 中国肺癌杂志, 2008,11(2):206-213
[2] Liu YF, Guan XX, Chen LB, Chen YT . Study on ERCC1, XPD and XPA polymorphisms for prediction of platinum-based chemotherapy sensitivity in non-small cell lung cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2008,15(17):1285-1288
柳艳飞, 管晓翔, 陈龙邦, 陈一天 . ERCC1与XPD和XPA的遗传多态性对非小细胞肺癌铂类化疗敏感性预测的研究[J]. 中华肿瘤防治杂志, 2008,15(17):1285-1288
[3] Meng FY, Zheng WY, Liu XL, Song LL, Xu B, Zhang Y . Clinical observation of curative effects of imatinib in treatment of 26 cases of chronic myeloid leukemia[J]. Zhonghua Xue Ye Xue Za Zhi, 2004,25(5):314-315
孟凡义, 郑维扬, 刘晓力, 宋兰林, 徐兵, 张钰 . 伊马替尼治疗慢性粒细胞白血病26例临床观察[J]. 中华血液学杂志, 2004,25(5):314-315
[4] Xu WT, Li R . Efficacy of imatinib mesylate in treatment of advanced gastrointestinal stromal tumors[J]. Di Er Jun Yi Da Xue Xue Bao, 2005,26(5):583-584
徐文通, 李荣 . 甲磺酸伊马替尼治疗晚期胃肠道恶性间质瘤疗效的初步观察[J]. 第二军医大学学报, 2005,26(5):583-584
[5] Ma D . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. Xun Zheng Yi Xue, 2006,6(5):277-280
doi: 10.3969/j.issn.1671-5144.2006.05.007
马冬 . 贝伐单抗联合依立替康、氟尿嘧啶/甲酰四氢叶酸对转移性结直肠癌的治疗[J]. 循证医学, 2006,6(5):277-280
doi: 10.3969/j.issn.1671-5144.2006.05.007
[6] Wang T, Luo LL . A systematic review of bevacizumab for non-small cell lung cancer[J]. Zhongguo Shi Yong Yi Yao, 2008,3(5):1-2
王艇, 罗黎力 . 贝伐单抗治疗晚期非小细胞肺癌的系统评价[J]. 中国实用医药, 2008,3(5):1-2
[1] Zhao-guo Li , Rui-qiang Liu. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases in Internal Medicine (Part 5). Journal of Chinese Integrative Medicine, 2012, 10(9): 1061-1065.
[2] Avijit Paul, Kausik Bishayee, Samrat Ghosh, Avinaba Mukherjee, Sourav Sikdar, Debrup Chakraborty, Naoual Boujedaini, Anisur Rahman Khuda-Bukhsh. Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways. Journal of Chinese Integrative Medicine, 2012, 10(9): 1025-1038.
[3] Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996.
[4] Chen Xia , Qun-bang Zhu, Feng Huang, Jing-hui Huang, Hong-da Chen, Ming-jun Chen, Wei Gu, Bai Li, Fan-fu Fang, Liang-neng Wu . Traditional Chinese medicine constitution types in 127 elderly patients with insomnia: An investigation in communities of Yangpu District, Shanghai. Journal of Chinese Integrative Medicine, 2012, 10(8): 866-873.
[5] Yong Zhang, Xiao-wen Sun, Jian-hua Xu, Hai Lu, Zhong-ze Fan, Jue Sun, Xiao-xiao Zhang. Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells. Journal of Chinese Integrative Medicine, 2012, 10(8): 901-910.
[6] Claudia Maria Sous, Mario Goncalves, Jorge Machado, Thomas Efferth, Tobias Greten , Petra Froeschen , Henry J. Greten. Effects of qigong on performance-related anxiety and physiological stress functions in transverse flute music schoolchildren: A feasibility study. Journal of Chinese Integrative Medicine, 2012, 10(8): 858-865.
[7] Zhao-guo Li . Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases in Internal Medicine (Part 4). Journal of Chinese Integrative Medicine, 2012, 10(8): 948-952.
[8] Zhao-guo Li. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases in Internal Medicine (Part 3). Journal of Chinese Integrative Medicine, 2012, 10(7): 827-831.
[9] Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737.
[10] Ping Li, Yun-zhong Shi . A study on English translation of antithesis in Neijing. Journal of Chinese Integrative Medicine, 2012, 10(7): 832-836.
[11] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[12] Ju-yong Wang, Jing Guo, Chang-sheng Dong, Zhan Zheng, Qing Wang. Effects of Feiyanning Decoction, a compound traditional Chinese medicine, on iNOS and COX-2 expressions induced by tumor necrosis factor-α in lung adenocarcinoma cell line. Journal of Chinese Integrative Medicine, 2012, 10(6): 695-700.
[13] Ying-fei Bi , Jing-yuan Mao , Xian-liang Wang , Ya-zhu Hou , Yi-zhu Lu , Shan Bin Soh , Bo-li Zhang. Clinical epidemiology survey of the traditional Chinese medicine etiology and syndrome differentiation of coronary artery disease: Study protocol of a multicenter trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 619-627.
[14] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640.
[15] Yogesh Bendale, Vineeta Bendale, Saili Paul, Soumya Sundar Bhattacharyya. Green synthesis, characterization and anticancer potential of platinum nanoparticles Bioplatin. Journal of Chinese Integrative Medicine, 2012, 10(6): 681-689.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[6] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[7] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[8] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[9] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228
[10] Liang-ping Hu, Xiao-lei Bao. Three-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(11): 1229-1232
[an error occurred while processing this directive]